http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#Head http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#assertion http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#provenance http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#pubinfo http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#assertion http://purl.obolibrary.org/obo/DOID_7148 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_7148 http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01281 http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association http://www.w3.org/2000/01/rdf-schema#label orencia is a selective t cell costimulation modulator indicated for adult rheumatoid arthritis ra 1 1 1 1 juvenile idiopathic arthritis 1 2 1 2 adult psoriatic arthritis psa 1 3 1 3 important limitations of use 1 4 1 4 5 1 orencia r orencia is indicated for reducing signs and symptoms in patients 2 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis orencia may be used as monotherapy or concomitantly with methotrexate mtx orencia is indicated for the treatment of adult patients with active psoriatic arthritis psa orencia should not be administered concomitantly with tnf antagonists orencia is not recommended for use concomitantly with other biologic rheumatoid arthritis ra therapy such as anakinra http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01281 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#provenance http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#pubinfo http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#sig http://purl.org/nanopub/x/hasSignature FbZUsRIWQk13ON0qa92JaJ7E2ZQGYsOxQ4F/Q9v+oRTGm3qiJXFfsiXRhs/7XNrwxWrdLMgPposqi1BtX8CE7IqhWTHR69HbkBdmZzZgYWC4xQ9lCM2GDCIqkXFqgHJhQnwnnzMezkBUokK4zH3RGT+LfQkRjy80LRqs+5K9it0= http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 http://purl.org/dc/terms/created 2021-06-12T12:38:34.922+02:00 http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAiN44emSZ4jKhIYxOdE0op-3bvqTZF2OASOELEQhBPr0 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs